Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy

BACKGROUND: Blocking of the Tumor Necrosis Factor (TNF) activity is a successful therapeutic approach for 50–60% of rheumatoid arthritis (RA) patients. However, there are yet no biomarkers to stratify patients for anti-TNF therapy. Rheumatoid factor (RF) and anti-cyclic-citrullinated antibodies (ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Julià, Antonio, López-Lasanta, María, Blanco, Francisco, Gómez, Antonio, Haro, Isabel, Mas, Antonio Juan, Erra, Alba, Vivar, Ma Luz García, Monfort, Jordi, Sánchez-Fernández, Simón, González, Isidoro, Alperi, Mercedes, Castellanos-Moreira, Raúl, Fernández-Nebro, Antonio, Díaz-Torné, César, Palau, Núria, Lastra, Raquel, Lladós, Jordi, Sanmartí, Raimon, Marsal, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061050/
https://www.ncbi.nlm.nih.gov/pubmed/33882889
http://dx.doi.org/10.1186/s12891-021-04248-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061050/
https://www.ncbi.nlm.nih.gov/pubmed/33882889
http://dx.doi.org/10.1186/s12891-021-04248-y

Ejemplares similares